205 related articles for article (PubMed ID: 28607934)
1. Opioid Addiction: Social Problems Associated and Implications of Both Current and Possible Future Treatments, including Polymeric Therapeutics for Giving Up the Habit of Opioid Consumption.
Benéitez MC; Gil-Alegre ME
Biomed Res Int; 2017; 2017():7120815. PubMed ID: 28607934
[TBL] [Abstract][Full Text] [Related]
2. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management.
Pergolizzi JV; Raffa RB; Rosenblatt MH
J Clin Pharm Ther; 2020 Oct; 45(5):892-903. PubMed ID: 31986228
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
Kleber HD
Dialogues Clin Neurosci; 2007; 9(4):455-70. PubMed ID: 18286804
[TBL] [Abstract][Full Text] [Related]
4. Maintenance medication for opiate addiction: the foundation of recovery.
Bart G
J Addict Dis; 2012; 31(3):207-25. PubMed ID: 22873183
[TBL] [Abstract][Full Text] [Related]
5. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Chalhoub RM; Kalivas PW
Drugs; 2020 Oct; 80(15):1509-1524. PubMed ID: 32776315
[TBL] [Abstract][Full Text] [Related]
6. From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States.
Jaffe JH; O'Keeffe C
Drug Alcohol Depend; 2003 May; 70(2 Suppl):S3-11. PubMed ID: 12738346
[TBL] [Abstract][Full Text] [Related]
7. Impact of synthetic cannabinoids on the duration of opioid-related withdrawal and craving among patients of addiction clinics in Kazakhstan: A prospective case-control study.
Prilutskaya M; Bersani FS; Corazza O; Molchanov S
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631421
[TBL] [Abstract][Full Text] [Related]
8. Targeting Opioid Receptors in Addiction and Drug Withdrawal: Where Are We Going?
Tabanelli R; Brogi S; Calderone V
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446064
[TBL] [Abstract][Full Text] [Related]
9. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
Carswell N; Angermaier G; Castaneda C; Delgado F
Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
[TBL] [Abstract][Full Text] [Related]
10. Opioid dependence treatment: options in pharmacotherapy.
Stotts AL; Dodrill CL; Kosten TR
Expert Opin Pharmacother; 2009 Aug; 10(11):1727-40. PubMed ID: 19538000
[TBL] [Abstract][Full Text] [Related]
11. Opioid dependence.
Benich JJ
Prim Care; 2011 Mar; 38(1):59-70. PubMed ID: 21356421
[TBL] [Abstract][Full Text] [Related]
12. Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
Ahmadi J; Razeghian Jahromi L
Trials; 2017 Jun; 18(1):259. PubMed ID: 28587620
[TBL] [Abstract][Full Text] [Related]
13. The pharmacological treatment of opioid addiction--a clinical perspective.
Lobmaier P; Gossop M; Waal H; Bramness J
Eur J Clin Pharmacol; 2010 Jun; 66(6):537-45. PubMed ID: 20169438
[TBL] [Abstract][Full Text] [Related]
14. Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial.
Mannelli P; Patkar AA; Peindl K; Gorelick DA; Wu LT; Gottheil E
Addict Biol; 2009 Apr; 14(2):204-13. PubMed ID: 18715283
[TBL] [Abstract][Full Text] [Related]
15. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
Wachholtz A; Gonzalez G
Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
[TBL] [Abstract][Full Text] [Related]
17. Day-to-day opioid withdrawal symptoms, psychological distress, and opioid craving in patients with chronic pain prescribed opioid therapy.
Bruneau A; Frimerman L; Verner M; Sirois A; Fournier C; Scott K; Perez J; Shir Y; Martel MO
Drug Alcohol Depend; 2021 Aug; 225():108787. PubMed ID: 34091157
[TBL] [Abstract][Full Text] [Related]
18. Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.
Bisaga A; Mannelli P; Sullivan MA; Vosburg SK; Compton P; Woody GE; Kosten TR
Am J Addict; 2018 Apr; 27(3):177-187. PubMed ID: 29596725
[TBL] [Abstract][Full Text] [Related]
19. [Drug therapy of opioid withdrawal].
Cortese S; Risso M
Vertex; 2008; 19(77):522-6. PubMed ID: 18443666
[TBL] [Abstract][Full Text] [Related]
20. Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.
Moratti E; Kashanpour H; Lombardelli T; Maisto M
Clin Drug Investig; 2010; 30 Suppl 1():3-11. PubMed ID: 20450240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
